These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 1061256)

  • 1. [Post-transfusion HL-A alloimmunization in acute leukemia].
    Jeannet M; Wyss M; Babel JF; Regamey A
    Schweiz Med Wochenschr; 1975 Nov; 105(47):1590-1. PubMed ID: 1061256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [HL-A system and blood transfusion].
    Jeannet M
    Schweiz Med Wochenschr; 1975 Jun; 105(24):780-2. PubMed ID: 1056624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Transfusion of leukocytes and platelets in the treatment of acute leukemia].
    Baklaja R; Stajić M; Banicević B; Jancić M; Cvetković V; Maslovarić S; Susaković N; Andelić M; Stefanović S
    Bilt Hematol Transfuz; 1978; 6(3):31-8. PubMed ID: 295220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Transfusion problems relative to the HL-A system].
    Mayr WR
    Infusionsther Klin Ernahr; 1977 Apr; 4(2):99-100. PubMed ID: 558167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alloimmunization following platelet transfusions in patients with acute nonlymphocytic leukemia.
    Nozaki H; Shimizu M; Komatsuda M; Watanabe K; Nagao T; Arimori S
    Tokai J Exp Clin Med; 1986 Aug; 11(3):201-4. PubMed ID: 3475819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bleeding risk and platelet transfusion refractoriness in patients with acute myelogenous leukemia who undergo autologous stem cell transplantation.
    Toor AA; Choo SY; Little JA
    Bone Marrow Transplant; 2000 Aug; 26(3):315-20. PubMed ID: 10967572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A raised incidence of HL-A2 plus HL-A9 and other anomalies of the HL-A antigens of patients with leukaemia.
    Dickson A
    Acta Haematol; 1975; 54(3):143-51. PubMed ID: 809957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Transfusion of blood with HL-A type. A study with 2,380 donors (author's transl)].
    Bouillenne C; Leclercq P; Brocteur J; André A
    Nouv Rev Fr Hematol Blood Cells; 1976; 16(2):203-8. PubMed ID: 985685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Thrombocyte substitution in acute leukemia. Effect of histocompatibility on the clinical efficacy].
    Kubel M; Freistedt B; Hammer P; Thierbach V; Helbig W; Haustein B; Schultze W
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(2):355-64. PubMed ID: 6179839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current status of leukocyte and platelet administration in cancer therapy.
    Walker EM; Cannon A; Mitchum EN
    Ann Clin Lab Sci; 1983; 13(6):453-73. PubMed ID: 6197928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological reactions involving leukocytes: II. Studies of a patient with multiple transfusion-induced allogeneic antibodies to leukocytes.
    Bilezikian SB; Tsan MF; Laleli YR; Bias WB; Hodkinson B; McIntyre PA
    Johns Hopkins Med J; 1976 Mar; 138(3):73-8. PubMed ID: 1255926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Role of the HL-A system in the transfusion of platelets and leukocytes].
    Mannoni P; Rodet M; Bracq C
    Rev Fr Transfus Immunohematol; 1977 Mar; 20(1):49-55. PubMed ID: 268002
    [No Abstract]   [Full Text] [Related]  

  • 13. HPA antibodies in Algerian multitransfused patients: Prevalence and involvement in platelet refractoriness.
    Brouk H; Bertrand G; Zitouni S; Djenouni A; Martageix C; Griffi F; Kaplan C; Ouelaa H
    Transfus Apher Sci; 2015 Jun; 52(3):295-9. PubMed ID: 25620758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistence of lymphocytotoxic antibodies in patients in the trial to reduce alloimmunization to platelets: implications for using modified blood products.
    Slichter SJ; Bolgiano D; Kao KJ; Kickler TS; McFarland J; McCullough J; Woodson R
    Transfus Med Rev; 2011 Apr; 25(2):102-10. PubMed ID: 21345638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Platelet alloimmunization in patients with oncologic blood disorders treated with multiple transfusions: prospective study in adults and children].
    Pereira J; Bronfman L; Bertín P; Marzouka E; Hidalgo P; Amaya S; Mezzano D
    Rev Med Chil; 1997 Nov; 125(11):1305-12. PubMed ID: 9609051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anti-HL-A immunization in polytransfused patients according to the antigenic composition of the transfused blood].
    Bouillenne C; Leclercq P; Brocteur J; Servais M; Bustin J; André A
    Nouv Rev Fr Hematol Blood Cells; 1976; 16(2):209-20. PubMed ID: 972831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized trial of leukocyte-depleted platelet transfusion to modify alloimmunization in patients with leukemia.
    Schiffer CA; Dutcher JP; Aisner J; Hogge D; Wiernik PH; Reilly JP
    Blood; 1983 Oct; 62(4):815-20. PubMed ID: 6349715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Transfusion strategy in substitution with thrombocytes and granulocytes].
    Wiesneth M
    Beitr Infusionther Klin Ernahr; 1987; 18():108-14. PubMed ID: 2830874
    [No Abstract]   [Full Text] [Related]  

  • 19. Combined granulocyte and platelet transfusions. Development of alloimmunization as reflected by decreasing cell recovery values.
    Ford JM; Brown LM; Cullen MH; Oliver RT; Wadsworth J; Lister TA
    Transfusion; 1982; 22(6):498-503. PubMed ID: 6959405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of the proteolytic enzyme brinase to produce autocytotoxicity in patients with acute leukemia and its possible role in immunotherapy.
    Thornes RD; Deasy PF; Carroll R; Reen DJ; MacDonnel JD
    Cancer Res; 1972 Feb; 32(2):280-4. PubMed ID: 4512605
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.